Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | EVP and CFO | September 21, 2026 | September 23, 2026 |
| CONMED CorpCNMD · Entity 4691 | Executive Vice President & CFO | November 06, 2025 | November 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date September 21, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,688 |
Reported balance
After 2026-09-21 transaction · row 1
1 source rowRow 1 · 2026-09-21 · Grant · Acquired 49,688 · Balance 49,688 F1: Reflects a grant of restricted stock units that vest in two equal annual installments beginning on September 21, 2027. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.61 · Expires 2036-09-21 | Direct | 138,632 |
Reported balance
After 2026-09-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-21 · Grant · Acquired 138,632 · Balance 138,632 F2: Reflects a grant of stock options that vest in three equal annual installments beginning on September 21, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vest in two equal annual installments beginning on September 21, 2027.
F2: Reflects a grant of stock options that vest in three equal annual installments beginning on September 21, 2027.
CONMED Corp
Report date November 06, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,836 |
Reported balance
After 2025-11-06 transaction · row 1
1 source rowRow 1 · 2025-11-06 · Sale · Disposed 3,500 · Balance 1,836 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2021 Filed Aug 16, 2021 21:48 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,350 | $122.76 | $165,726.00 |
DisclosureSEC source: 0001127602-21-023805 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2021. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 19:04 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 960 | $137.04 | $131,558.40 |
DisclosureSEC source: 0001127602-21-020009 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,672 Read SEC document |
| June 15, 2021 Filed Jun 22, 2021 20:20 UTC Amendment | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 960 | $137.04 | $131,558.40 |
DisclosureSEC source: 0001127602-21-020494 · form4a.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,672 F1 · kind: This Amended Form 4 is being filed because the previous Form 4, while correctly noting the shares sold, did not note that the sale had been effected pursuant to a previously adopted 10b5-1 Written Plan. Read SEC document |
| May 14, 2021 Filed May 18, 2021 14:43 UTC | CONMED Corp CNMD · Entity 4691 | GiftCommon Stock | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017111 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,632 Read SEC document |
| May 14, 2021 Filed May 18, 2021 14:43 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,257 | $141.19 | $177,475.83 |
DisclosureSEC source: 0001127602-21-017111 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,944 Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:55 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 191 | $124.06 | $23,695.46 |
DisclosureSEC source: 0001127602-21-012808 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,201 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:18 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 45,050 | $0.00 Strike: $122.55 | $0.00 |
DisclosureSEC source: 0001127602-21-009284 · form4.xml · derivative · entry 4 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,050 Underlying: Common Stock · 45,050 shares Expires 2031-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009284 · form4.xml · derivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 1,600 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:18 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 469 | $122.55 | $57,475.95 |
DisclosureSEC source: 0001127602-21-009284 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,010 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009284 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:16 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000980 · form4.xml · derivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:16 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 980 | $111.35 | $109,123.00 |
DisclosureSEC source: 0001127602-21-000980 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,549 Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:16 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000980 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 8, 2021 22:36 UTC Amendment | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 650 | $111.35 | $72,377.50 |
DisclosureSEC source: 0001127602-21-001294 · form4a.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,879 F1 · shares: Initial Form 4 indicated incorrect shares withheld due to calculation error by brokerage firm. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:11 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 224 | $54.41 | $12,187.84 |
DisclosureSEC source: 0001127602-20-012790 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,529 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:30 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 53,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · derivative · entry 4 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:30 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · derivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 1,600 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:30 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 784 | $94.64 | $74,197.76 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,305 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:30 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:44 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000583 · form4.xml · derivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:44 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 1,040 | $111.23 | $115,679.20 |
DisclosureSEC source: 0001127602-20-000583 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,489 Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:44 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000583 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 21:00 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 300 | $79.02 | $23,706.00 |
DisclosureSEC source: 0001127602-19-014223 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,529 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:36 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 48,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-19-009951 · form4.xml · derivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2029-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:36 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 6,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009951 · form4.xml · derivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 Underlying: Common Stock · 6,400 shares Expires 2029-03-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 17:24 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000511 · form4.xml · derivative · entry 4 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 17:24 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 1,086 | $63.41 | $68,863.26 |
DisclosureSEC source: 0001127602-19-000511 · form4.xml · nonDerivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,229 Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 17:24 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000511 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:24 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 174 | $60.99 | $10,612.26 |
DisclosureSEC source: 0001127602-19-000511 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 17:17 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 141 | $75.26 | $10,611.66 |
DisclosureSEC source: 0001127602-18-028929 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141 Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:39 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 8,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000975 · form4.xml · derivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2028-01-02 F2 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:39 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 48,000 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-18-000975 · form4.xml · derivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.